## Core Concept
Sickle cell anemia is a genetic disorder caused by a mutation in the HBB gene that codes for the beta-globin subunit of hemoglobin, leading to the production of abnormal hemoglobin (HbS). This results in red blood cells that can assume a sickle shape under certain conditions, causing vaso-occlusion and hemolysis. The management of sickle cell anemia focuses on alleviating symptoms, preventing complications, and improving quality of life.

## Why the Correct Answer is Right
The best treatment for sickle cell anemia is **Hydroxyurea (also known as hydroxycarbamide)**, which is a medication that increases fetal hemoglobin (HbF) production. Elevated levels of HbF reduce the polymerization of HbS and thus decrease the sickling of red blood cells. This leads to a decrease in the frequency of painful crises and may also reduce the risk of other complications. Hydroxyurea has been shown to be effective in reducing the incidence of vaso-occlusive crises and may have other beneficial effects on the disease.

## Why Each Wrong Option is Incorrect
- **Option A:** Blood transfusions are used in the management of sickle cell anemia but are not considered the best treatment for all patients. They can help increase the concentration of normal red blood cells but carry risks such as iron overload and alloimmunization.
- **Option B:** Iron chelation therapy is used in patients with sickle cell anemia who receive frequent blood transfusions to prevent iron overload. It is not a treatment for the underlying disease process.
- **Option C:** Bone marrow transplantation (hematopoietic stem cell transplantation) is a potentially curative treatment for sickle cell anemia but is limited by the availability of a matched donor and the risks associated with the procedure. It is not widely available or suitable for all patients.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **hydroxyurea** is a cornerstone in the management of sickle cell disease for patients with recurrent vaso-occlusive crises. It works by increasing fetal hemoglobin levels, which helps to mitigate the disease's pathophysiology.

## Correct Answer: D. Hydroxyurea.